A randomized controlled trial of a smoking cessation intervention conducted among prisoners
Aim: To evaluate the efficacy of nortriptyline (NOR) added to a multi-component smoking cessation intervention, which included cognitive-behavioural therapy (CBT) and provision of nicotine replacement therapy (NRT). Design: Randomized controlled trial (RCT) comparing two study groups with blinded fo...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
2013
|
| Online Access: | http://hdl.handle.net/20.500.11937/11381 |
| _version_ | 1848747790616756224 |
|---|---|
| author | Richmond, R. Indig, D. Butler, Tony Wilhelm, K. Archer, V. Wodak, A. |
| author_facet | Richmond, R. Indig, D. Butler, Tony Wilhelm, K. Archer, V. Wodak, A. |
| author_sort | Richmond, R. |
| building | Curtin Institutional Repository |
| collection | Online Access |
| description | Aim: To evaluate the efficacy of nortriptyline (NOR) added to a multi-component smoking cessation intervention, which included cognitive-behavioural therapy (CBT) and provision of nicotine replacement therapy (NRT). Design: Randomized controlled trial (RCT) comparing two study groups with blinded follow-up at 3, 6 and 12 months. Both groups received a multi-component smoking cessation intervention comprising two half-hour individual sessions of CBT and NRT with either active NOR or placebo. Setting: Prisons in New South Wales (17) and Queensland (one), Australia. Participants: A total of 425 male prisoners met inclusion criteria and were allocated to either treatment (n=206) or control group (n=219). Measurements: Primary end-points at 3, 6 and 12 months were continuous abstinence, point prevalence abstinence and reporting a 50% reduction in smoking. Smoking status was confirmed by expired carbon monoxide, using a cut-point of =10 parts per million. Findings: Participants' demographics and baseline tobacco use were similar in treatment and control groups. Based on an intention-to-treat analysis, continuous abstinence between the treatment and control groups was not significantly different at 3 months (23.8 versus 16.4%), 6 months (17.5 versus 12.3%) and 12 months (11.7 versus 11.9%). Conclusion: Adding nortriptyline to a smoking cessation treatment package consisting of behavioural support and nicotine replacement therapy does not appear to improve long-term abstinence rates in male prisoners. © 2012 The Authors, Addiction © 2012 Society for the Study of Addiction. |
| first_indexed | 2025-11-14T06:54:45Z |
| format | Journal Article |
| id | curtin-20.500.11937-11381 |
| institution | Curtin University Malaysia |
| institution_category | Local University |
| last_indexed | 2025-11-14T06:54:45Z |
| publishDate | 2013 |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | curtin-20.500.11937-113812017-09-13T14:55:42Z A randomized controlled trial of a smoking cessation intervention conducted among prisoners Richmond, R. Indig, D. Butler, Tony Wilhelm, K. Archer, V. Wodak, A. Aim: To evaluate the efficacy of nortriptyline (NOR) added to a multi-component smoking cessation intervention, which included cognitive-behavioural therapy (CBT) and provision of nicotine replacement therapy (NRT). Design: Randomized controlled trial (RCT) comparing two study groups with blinded follow-up at 3, 6 and 12 months. Both groups received a multi-component smoking cessation intervention comprising two half-hour individual sessions of CBT and NRT with either active NOR or placebo. Setting: Prisons in New South Wales (17) and Queensland (one), Australia. Participants: A total of 425 male prisoners met inclusion criteria and were allocated to either treatment (n=206) or control group (n=219). Measurements: Primary end-points at 3, 6 and 12 months were continuous abstinence, point prevalence abstinence and reporting a 50% reduction in smoking. Smoking status was confirmed by expired carbon monoxide, using a cut-point of =10 parts per million. Findings: Participants' demographics and baseline tobacco use were similar in treatment and control groups. Based on an intention-to-treat analysis, continuous abstinence between the treatment and control groups was not significantly different at 3 months (23.8 versus 16.4%), 6 months (17.5 versus 12.3%) and 12 months (11.7 versus 11.9%). Conclusion: Adding nortriptyline to a smoking cessation treatment package consisting of behavioural support and nicotine replacement therapy does not appear to improve long-term abstinence rates in male prisoners. © 2012 The Authors, Addiction © 2012 Society for the Study of Addiction. 2013 Journal Article http://hdl.handle.net/20.500.11937/11381 10.1111/add.12084 unknown |
| spellingShingle | Richmond, R. Indig, D. Butler, Tony Wilhelm, K. Archer, V. Wodak, A. A randomized controlled trial of a smoking cessation intervention conducted among prisoners |
| title | A randomized controlled trial of a smoking cessation intervention conducted among prisoners |
| title_full | A randomized controlled trial of a smoking cessation intervention conducted among prisoners |
| title_fullStr | A randomized controlled trial of a smoking cessation intervention conducted among prisoners |
| title_full_unstemmed | A randomized controlled trial of a smoking cessation intervention conducted among prisoners |
| title_short | A randomized controlled trial of a smoking cessation intervention conducted among prisoners |
| title_sort | randomized controlled trial of a smoking cessation intervention conducted among prisoners |
| url | http://hdl.handle.net/20.500.11937/11381 |